Meeting ReportBreast Cancer
A Prospective Clinical Trial of 18F-Fluorestradiol (FES) PET/CT Compared to Standard of Care Imaging in Patients with Newly Diagnosed and Suspected Recurrent Breast Cancer
Gary Ulaner, Melvin Silverstein, Louis Vandermolen, Chaitali Nangia, Merry Tetef and Beth Thomsen
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2590;
Gary Ulaner
1Hoag Family Cancer Institute
Melvin Silverstein
1Hoag Family Cancer Institute
Louis Vandermolen
1Hoag Family Cancer Institute
Chaitali Nangia
1Hoag Family Cancer Institute
Merry Tetef
2UCLA
Beth Thomsen
1Hoag Family Cancer Institute

Article Figures & Data
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
A Prospective Clinical Trial of 18F-Fluorestradiol (FES) PET/CT Compared to Standard of Care Imaging in Patients with Newly Diagnosed and Suspected Recurrent Breast Cancer
Gary Ulaner, Melvin Silverstein, Louis Vandermolen, Chaitali Nangia, Merry Tetef, Beth Thomsen
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2590;
A Prospective Clinical Trial of 18F-Fluorestradiol (FES) PET/CT Compared to Standard of Care Imaging in Patients with Newly Diagnosed and Suspected Recurrent Breast Cancer
Gary Ulaner, Melvin Silverstein, Louis Vandermolen, Chaitali Nangia, Merry Tetef, Beth Thomsen
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2590;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.